News

Nephros to Present at the Benchmark Company 10th Annual One-on-One Discovery Conference

SOUTH ORANGE, NJ – (NewMediaWire) – November 23, 2021 – Nephros, Inc. (Nasdaq: NEPH), a leading
water technology company providing innovative filtration and pathogen detection
solutions to healthcare and commercial markets, today announced that Andy
Astor, Chief Executive Officer of Nephros will be attending the Benchmark
Company 10th Annual One-on-One Discovery Conference. The conference
is taking place virtually on December 2, 2021, in a one-on-one and small group
meeting format. The invitation-only event is for institutional clients of the Benchmark
Company. For additional details, please contact Director of Corporate Access,
Vince Curatola, at 414-203-5556.

About the
Benchmark Company

The Benchmark Company is
an institutionally focused, research driven, sales, trading & investment
banking firm. Over the last 35 years, we have been steadfastly dedicated to our
mission of fostering the long-term success of our clients. Our goal is to
provide significant value by leveraging the resources that exist across our
broad platform. This approach has enabled us to offer unbiased guidance and exceptional
transaction execution to a broad range of clients over a variety of market
conditions. For more information, please visit www.benchmarkcompany.com.

About Nephros

Nephros, Inc. is a company committed
to improving the human relationship with water through leading, accessible
technology. We provide innovative filtration and pathogen detection as part of
an integrated approach to water safety that combines science, solutions, and
support services. Nephros products serve the needs of customers within the
healthcare and commercial markets, offering both proactive and emergency
responses for water management.

For more
information about Nephros, please visit
www.nephros.com.

Investor Relations Contacts:

Kirin Smith, President

PCG Advisory, Inc.

(646) 823-8656

ksmith@pcgadvisory.com

 

Andy Astor, CEO

Nephros,
Inc.

(201) 345-0824

andy@nephros.com

Source link

Show More

Related Articles

Back to top button